Sabra Mazin's Insider Trades & SAST Disclosures
Sabra Mazin's most recent trade in ClearPoint Neuro Inc was a trade of 13,050 Restricted Stock Units done . Disclosure was reported to the exchange on March 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sabra Mazin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 13,050 | 52,202 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 13,050 | 57,830 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.18 per share. | 12 Mar 2025 | 6,627 | 51,203 (0%) | 0% | 13.2 | 87,344 | Common Stock |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 13,827 | 51,802 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 13,827 | 13,827 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.19 per share. | 06 Mar 2025 | 7,022 | 44,780 (0%) | 0% | 13.2 | 92,620 | Common Stock |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 33,210 | 33,210 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 4.53 per share. | 31 Dec 2024 | 784 | 37,975 (0%) | 0% | 4.5 | 3,552 | Common Stock |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.39 per share. | 10 Oct 2024 | 7,465 | 37,191 (0%) | 0% | 11.4 | 85,026 | Common Stock |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 4.58 per share. | 28 Jun 2024 | 767 | 44,656 (0%) | 0% | 4.6 | 3,513 | Common Stock |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 65,252 | 65,252 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 6,913 | 27,654 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 6,913 | 47,352 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.24 per share. | 06 Mar 2024 | 3,463 | 43,889 (0%) | 0% | 6.2 | 21,609 | Common Stock |
| ClearPoint Neuro Inc | Sabra Mazin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 5.77 per share. | 29 Dec 2023 | 590 | 40,439 (0%) | 0% | 5.8 | 3,404 | Common Stock |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 6.15 per share. | 30 Jun 2023 | 552 | 47,452 (0%) | 0% | 6.2 | 3,395 | Common Stock |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 34,567 | 34,567 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 11,522 | 11,522 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Mazin Sabra | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2022 | 46,000 | 46,900 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges